Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Receivables - Other: 2024-2025

Historic Receivables - Other for Centessa Pharmaceuticals (CNTA) over the last 1 years, with Sep 2025 value amounting to $1.9 million.

  • Centessa Pharmaceuticals' Receivables - Other was N/A to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $287,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Centessa Pharmaceuticals' Receivables - Other is $1.9 million, which was down 14.10% from $2.2 million recorded in Q2 2025.
  • Centessa Pharmaceuticals' 5-year Receivables - Other high stood at $2.2 million for Q2 2025, and its period low was $287,000 during Q4 2024.
  • Its 2-year average for Receivables - Other is $1.5 million, with a median of $1.6 million in 2025.